Baker Avenue Asset Management’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$427K Buy
4,961
+2,549
+106% +$224K 0.01% 564
2026
Q1
$218K Buy
+2,412
New +$221K ﹤0.01% 705
2023
Q4
Sell
-127
Closed -$14.3K 1540
2023
Q3
$14.3K Buy
127
+7
+6% +$889 ﹤0.01% 706
2023
Q2
$17.5K Hold
120
﹤0.01% 671
2023
Q1
$15.5K Hold
120
﹤0.01% 701
2022
Q4
$15.3K Buy
+120
New +$13.9K ﹤0.01% 658

Other funds holding ZBH

Baker Avenue Asset Management's ZBH Position: Q2 2026 in Review

Baker Avenue Asset Management increased its Zimmer Biomet (ZBH) stake by 106% in Q2 2026, buying an estimated $224K and bringing the position to 4,961 shares worth $427K. The position accounts for 0.01% of the portfolio, ranked #564.

Baker Avenue Asset Management first reported a position in ZBH in Q4 2022 and has held it in 6 quarters since. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Baker Avenue Asset Management held 4,961 shares of Zimmer Biomet worth $427K as of Q2 2026.
  • Baker Avenue Asset Management bought 2,549 Zimmer Biomet shares in Q2 2026, an estimated $224K.
  • Zimmer Biomet made up 0.01% of Baker Avenue Asset Management's portfolio in Q2 2026, its #564 holding.
  • Baker Avenue Asset Management first reported a position in Zimmer Biomet in Q4 2022 and has held it in 6 quarters since.
  • 906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Baker Avenue Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.